Breast cancer drug biggest cancer development of 2005

12/27/2005 | USA Today

Evidence that the drug Herceptin can reduce by half the risk of a relapse of early-stage breast cancer is the most exciting development in cancer of 2005, experts say. Researchers also found that use of Herceptin with chemotherapy reduced the risk of death by one-third.

View Full Article in:

USA Today

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA